Paper · 39744628
Tumor microenvironment in oral squamous cell carcinoma.
Li C and 2 others. Front Immunol, 2024. Cited by 66 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Tumor microenvironment in oral squamous cell carcinoma. Papers, record 39744628. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39744628
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Tumor Microenvironment | Major topic |
| Mouth Neoplasms | Major topic |
| Carcinoma, Squamous Cell | Major topic |
| Humans | |
| Animals | |
| Tumor-Associated Macrophages | |
| Cancer-Associated Fibroblasts | |
| Squamous Cell Carcinoma of Head and Neck | |
| Dendritic Cells |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References140
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34,502,382 | Oral Squamous Cell Carcinoma Contributes to Differentiation of Monocyte-Derived Tumor-Associated Macrophages via PAI-1 and IL-8 Production. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34502382 | PubMed |
| 2 | 32,347,186 | Foxp3+ Regulatory T Cells Associated With CCL17/CCR4 Expression in Carcinomas of Dogs. | Vet Pathol | 2020 | https://conductscience.org/library/papers/32347186 | PubMed |
| 3 | 32,630,659 | Macrophages in Oral Carcinomas: Relationship with Cancer Stem Cell Markers and PD-L1 Expression. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32630659 | PubMed |
| 4 | 36,064,348 | MicroRNA-18a regulates the metastatic properties of oral squamous cell carcinoma cells via HIF-1α expression. | BMC Oral Health | 2022 | https://conductscience.org/library/papers/36064348 | PubMed |
| 5 | 34,041,037 | Pro-Tumorigenic Macrophage Infiltration in Oral Squamous Cell Carcinoma and Possible Macrophage-Aimed Therapeutic Interventions. | Front Oncol | 2021 | https://conductscience.org/library/papers/34041037 | PubMed |
| 6 | 33,194,026 | Upregulation of CSF-1 is correlated with elevated TAM infiltration and poor prognosis in oral squamous cell carcinoma. | Am J Transl Res | 2020 | https://conductscience.org/library/papers/33194026 | PubMed |
| 7 | 38,994,041 | Hsa_circRNA_101036 aggravates hypoxic-induced endoplasmic reticulum stress via the miR-21-3p/TMTC1 axis in oral squamous cell carcinoma. | Heliyon | 2024 | https://conductscience.org/library/papers/38994041 | PubMed |
| 8 | 34,319,010 | Tumor-infiltrating FoxP3+ T cells are associated with poor prognosis in oral squamous cell carcinoma. | Clin Exp Dent Res | 2022 | https://conductscience.org/library/papers/34319010 | PubMed |
| 9 | 34,217,360 | Tumor protein D52 is upregulated in oral squamous carcinoma cells under hypoxia in a hypoxia-inducible-factor-independent manner and is involved in cell death resistance. | Cell Biosci | 2021 | https://conductscience.org/library/papers/34217360 | PubMed |
| 10 | 35,844,605 | Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy. | Front Immunol | 2022 | https://conductscience.org/library/papers/35844605 | PubMed |
1 to 10 of 140
See all 140 referencesCited by58
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 66 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,984,972 | Single-Cell and Spatial Insights into Oral Squamous Cell Carcinoma: Towards Cell-State-Targeted Immunotherapy. | Oncol Res | 2026 | https://conductscience.org/library/papers/42984972 | PubMed |
| 42,964,316 | Profiling the MMP family genes as prognostic biomarkers in oral squamous cell carcinoma: from computational discovery to clinical validation in a South Indian cohort. | Front Bioinform | 2026 | https://conductscience.org/library/papers/42964316 | PubMed |
| 42,923,286 | Saliva as a window into tumor immunity in oral squamous cell carcinoma: tissue concordance and translational validation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42923286 | PubMed |
| 42,908,740 | PDGF-BB secreted by OTSCC orchestrates CAF-driven tumor progression through regulating the LINC00886/hsa-miR-15b-5p/AKT axis. | Am J Cancer Res | 2026 | https://conductscience.org/library/papers/42908740 | PubMed |
| 42,870,925 | Selenium metabolism-related gene TXNRD1 drives tumor progression and microenvironment remodeling in oral squamous cell carcinoma. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42870925 | PubMed |
| 42,862,405 | Immunotherapy for oral cavity tumors: recent advances, key challenges, and future perspectives. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42862405 | PubMed |
| 42,836,892 | Targeting oral cancer with curcumin and its structural analogs: molecular mechanisms, pharmacokinetic optimization, and clinical translation. | Arch Pharm Res | 2026 | https://conductscience.org/library/papers/42836892 | PubMed |
| 42,795,648 | Functional Heterogeneity of Fusobacterium nucleatum Subspecies in the Immune Microenvironment of Oral Squamous Cell Carcinoma. | Microorganisms | 2026 | https://conductscience.org/library/papers/42795648 | PubMed |
| 42,760,366 | From signals to phenotype: multifactorial drivers of tumor-associated macrophage polarization in oral cavity squamous cell carcinoma: a narrative review. | Eur Arch Otorhinolaryngol | 2026 | https://conductscience.org/library/papers/42760366 | PubMed |
| 42,707,371 | Anti-cancer effects of plant extracts in head and neck squamous cell carcinoma. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42707371 | PubMed |
1 to 10 of 58
See all 58 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39744628
GET https://conductscience.org/api/papers/v1/39744628/references?page=2